The features of HSCs in the context of aging and MDS are shown. With normal aging, there is an increase in the risk of the development of CHIP, but the contributions of and requirement for CHIP in aging phenotypes remain incompletely understood. Many functional characteristics of aged HSCs are accentuated in MDS, but the molecular events necessary to transition from CHIP to the clinically significant cytopenias seen in MDS remain unclear.